0001209191-17-051076.txt : 20170901
0001209191-17-051076.hdr.sgml : 20170901
20170901174326
ACCESSION NUMBER: 0001209191-17-051076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170626
FILED AS OF DATE: 20170901
DATE AS OF CHANGE: 20170901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Primiano Christopher Brett
CENTRAL INDEX KEY: 0001603510
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 171067057
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-26
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001603510
Primiano Christopher Brett
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
0
1
0
0
SVP, OPS, BUS DEV, GC & SEC
Common Stock
2017-06-26
4
S
0
805
10.0261
D
14881
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the weighted average sale price. These shares were sold in transactions at $10.00 and $10.07. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
Amount also reflects the number of shares sold by the reporting person as previously reported on the Form 4 filed on August 30, 2017 (the "Previous Form 4") as well as the acquisition of 2,062 shares under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan, which was previously disclosed on the Previous Form 4.
/s/Christopher B. Primiano
2017-09-01